1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
(
- Contribution to journal › Letter
- 2021
-
Mark
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4
+ T-Cell Responses.
(
- Contribution to journal › Article
- 2013
-
Mark
Evidence of association between type 1 diabetes and exposure to enterovirus in Cuban children and adolescents
(
- Contribution to journal › Article